63 results
8-K
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
, 2024, subject to the satisfaction of customary closing conditions.
The Shares will be issued pursuant to a Registration Statement on Form S-3 (File
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
and the Company shall deliver the other items required pursuant to Section 2.3 deliverable at the Closing. Upon satisfaction of the covenants … in the Registration Statement or the Prospectus or otherwise) shall have been complied with to the satisfaction of the Commission and the Underwriter
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
to stockholders after the payment of all of our debts and other liabilities, subject to the satisfaction of any liquidation preference granted
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
of all of our debts and other liabilities, subject to the satisfaction of any liquidation preference granted to the holders of any then outstanding
8-K
EX-10.1
nw5ym7
20 Feb 24
Departure of Directors or Certain Officers
4:44pm
424B4
0edf5ek
8 Jan 24
Prospectus supplement with pricing info
4:11pm
8-K
EX-10.1
7vx fg6ms
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
S-3
EX-4.4
s1p qf2eq7
23 Dec 22
Shelf registration
4:16pm
S-3
fuw0e
23 Dec 22
Shelf registration
4:16pm
S-3
EX-1.2
i1rixm d6
23 Dec 22
Shelf registration
4:16pm
8-K
EX-1.1
efd9simj
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
8-K
EX-99.2
hz6u2wqmmlfb
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
424B4
02cn9nhgkebs s4
14 Nov 22
Prospectus supplement with pricing info
6:02am